Related by context. Frequent words. (Click for all words.) 82 Phase IIb 81 Phase 2b trial 80 Phase 2a 80 Phase IIa trial 80 Phase 2a clinical 80 Phase IIb trial 80 Phase 2b clinical 79 Phase Ib 79 Phase 1b 79 Phase IIa 78 Phase III clinical 78 Phase IIb clinical 77 Phase 2b 77 Phase IIa clinical 77 pivotal Phase III 76 Phase III 74 Phase III trials 73 clinical trial 72 Phase III clinical trials 72 pivotal Phase 72 Phase III pivotal 71 multiple ascending dose 71 randomized Phase 71 dose escalation study 70 dose escalation 70 Phase II 69 PRX # 68 placebo controlled 68 clinical trials 68 randomized placebo controlled 67 RG# [001] 67 double blind placebo 66 randomized controlled 66 tolerability 66 IMGN# 66 investigational compound 66 multicenter 65 HspE7 65 blind randomized placebo 65 unblinded 65 DSMB 65 IND enabling 65 randomized double 64 randomized clinical 64 multicenter study 64 CRx 64 ZYBRESTAT 64 mipomersen 64 prospective randomized 64 oral formulation 64 pharmacokinetic 64 PF # [001] 64 INCB# [002] 63 preclinical 63 ISIS # 63 ADX# 63 ofatumumab 63 FOLOTYN 63 eculizumab 62 initiate Phase 62 LEVADEX 62 Zerenex 62 monotherapy 62 XL# [003] 62 MGCD# [001] 62 picoplatin 62 preclinical studies 62 mg dose 62 NDA submission 62 hormone refractory prostate cancer 61 tivozanib 61 AP# [003] 61 investigational drug 61 randomized 61 carfilzomib 61 IDX# 61 ASA# 61 safety tolerability 61 sunitinib 61 relapsing remitting multiple sclerosis 61 HRPC 61 tolerability profile 61 dosing regimens 61 LymphoStat B 61 pharmacokinetic profile 60 Locteron 60 blind randomized 60 ALTU 60 pharmacodynamics 60 blind placebo controlled 60 evaluable patients 60 non inferiority 60 efficacy 60 lubiprostone 60 pharmacokinetics 60 Marqibo 60 vandetanib 60 Phase 60 MDV# 60 plus ribavirin 59 pralatrexate